|
Aug 14
|
U.S. mRNA Therapeutics CDMO Market to Hit Valuation of US$ 6.27 Billion by 2033 | Astute Analytica
|
|
Aug 13
|
Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know
|
|
Aug 13
|
Moderna Stock Jumps as NIH Chief Tempers Administration’s Attack on mRNA
|
|
Aug 13
|
[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Aug 13
|
3 Reasons to Avoid MRNA and 1 Stock to Buy Instead
|
|
Aug 13
|
The 5 Most Interesting Analyst Questions From Moderna’s Q2 Earnings Call
|
|
Aug 13
|
MRNA Q2 Deep Dive: Revenue Beat Overshadowed by Lower Guidance and Cost Cuts
|
|
Aug 12
|
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
|
|
Aug 11
|
Find Oversold Stocks to Buy at a Discount With This Barchart Screener
|
|
Aug 11
|
mRNA Platform Strategic Business Analysis Report 2025 | Global Market to Reach $129.1 Billion by 2030 - Rising Infectious Diseases, Technological Advancements, and Pandemic Preparedness Drive Growth
|
|
Aug 11
|
The 3 Things That Matter for Moderna Now
|
|
Aug 9
|
Moderna, Inc. (MRNA)’s “Got The Double Whammy,” Says Jim Cramer
|
|
Aug 7
|
Alexandria Real Estate Equities, Inc. (ARE): A Bull Case Theory
|
|
Aug 7
|
Moderna Is Cutting 10,000 Jobs as Its Business Erodes. How Should You Play MRNA Stock Here?
|
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
|
Aug 7
|
RFK Jr’s mRNA funding halt signals “shift in US public health”
|
|
Aug 7
|
AI is already upending the corporate org chart as it flattens the distance between the C-suite and everyone else
|
|
Aug 6
|
Podcast: Stock Indexes Rise as Trump Boosts India Tariffs; Earnings in Focus
|
|
Aug 6
|
US Health Department Ending Federal mRNA Vaccine Development
|
|
Aug 6
|
Moderna Stock: Is Wall Street Bullish or Bearish?
|